IMPEL PHARMACEUTICALS INC: accounts_receivable

Value{"amount": 6801000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Period (as of 2023-06-30)
Statuscurrent
EntityIMPEL PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-23-043366 · Open the official SEC filing →
Retrieved: 2026-08-19T14:16:31.466222+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001445499/accounts-receivable/2023-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/b0416b05-2b02-487d-8216-e7452feb11ef

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies